Japan University, U.S. Firm To Share Disputed Stem-Cell Patent
This article was originally published in PharmAsia News
Executive Summary
Japan's Kyoto University has agreed with U.S. biotech iPierian to share patent rights to adult stem-cell technology, allowing each other to use the cells without charge